Table 4 General demographics and clinical information for four Rejectors (R) and seven Non-rejectors (NR).

From: Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens

 

R

NR

Total subjects

4

7

Time from Transplant to Sample collection (days)

2778 ± 1160

1162 ± 419

Age on day of sample collection (Years)

16.3 ± 4.7

4.6 ± 1.3

Gender (M:F)

3:1

4:3

Race (Caucasian: Other)

3:1

7:0

LTx:LKTx:ITx:LITx

3:0:1:0

5:1:0:1

Tacrolimus whole blood concentrations

7.4 ± 1.9

5.2 ± 1.0

  1. All four Rejectors used in this study experienced biopsy proven acute cellular rejection on the day of blood sampling. LTx: Liver transplant, LKTx: combined liver kidney transplant, ITx: Intestine transplant and LITx: combined liver intestine transplant.
Back to article page